Yasuo Irie

Title: Yasuo Irie: Innovator in Pyrimidine Metabolism

Introduction

Yasuo Irie is a notable inventor based in Woburn, MA (US). He has made significant contributions to the field of pharmacology, particularly in the area of pyrimidine metabolism. With a total of 2 patents, his work focuses on improving the assessment of drug metabolism in individuals.

Latest Patents

Yasuo Irie's latest patents include innovative methods for determining pyrimidine metabolic capacity. The first patent provides a method for measuring an individual's ability to metabolize fluorouracil drugs, such as 5-fluorouracil. This method involves administering a preparation containing a pyrimidine compound labeled with an isotope and assessing the in vivo metabolic capacity based on the behavior of an excreted metabolite. The second patent focuses on assessing sensitivity to pyrimidine drugs, specifically evaluating in vivo pyrimidine metabolizing activity. This is achieved by administering a preparation with a labeled pyrimidine compound and measuring the amount of excreted metabolite.

Career Highlights

Yasuo Irie is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to advance research in drug metabolism. His work has the potential to enhance treatment strategies for patients requiring fluorouracil drugs.

Collaborations

Yasuo has collaborated with notable colleagues, including Makoto Inada and Nobuhiro Ikei. Their combined expertise contributes to the innovative research being conducted at Otsuka Pharmaceutical.

Conclusion

Yasuo Irie's contributions to the field of pyrimidine metabolism through his patents and collaborations highlight his role as a significant inventor in pharmacology. His work aims to improve patient outcomes in drug therapy.